原发性肝细胞癌(HCC)手术切除仍为治疗的最佳方案。但由于早期诊断率不高,对约50％不能切除的HCC仍须行各种姑息性治疗。本文就35例中晚期肝细胞痼行肝动脉结扎(HAL),并经肝动脉、门静脉插管(HAL+HAC.PVC)灌注5-Fu、ADM、MMC联合化疗的疗效,与单纯肝动脉结扎(HAL)、单纯肝动脉插管化疗(HAC)、全身化疗进行分析比较,报告如下。 Surgical resection of primary hepatocellular carcinoma (HCC) remains the best treatment option. However, due to the low rate of early diagnosis, a variety of palliative treatments are still required for about 50% of unresectable HCC. In this paper, 35 patients with middle and advanced hepatocytes were treated with hepatic artery ligation (HAL) and hepatic artery, portal vein cannulation (HAL+HAC.PVC) was infused with 5-Fu, ADM, and MMC combined with chemotherapy, and hepatic artery ligation was performed alone. (HAL), simple hepatic arterial cannulation (HAC), and systemic chemotherapy were compared and reported as follows.